Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$12.17 - $17.52 $2,434 - $3,504
-200 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$11.22 - $14.46 $2,244 - $2,892
200 New
200 $3,000
Q1 2020

May 15, 2020

SELL
$3.03 - $10.58 $5,072 - $17,710
-1,674 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$5.34 - $9.09 $8,939 - $15,216
1,674 New
1,674 $13,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.8B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.